正电子发射断层显像剂[18F]FET前体药物的合成

以L-酪氨酸为原料,设计并合成了6个正电子发射断层显像剂[18F]FET前体药物,其中5个未见文献报道,其结构经1H NMR,IR,MS和元素分析表征.     

糖类研究（XVI）：大环化合物Clemochinenoside—A前体的合成

近年来，人们发现许多含糖物质具有较强的生物活性，如许多大环内脂的糖单元具有抗菌及抗癌活性等［‘”j．糖缀合物的这些重要生物活性已引起人们的极大兴趣．铁线莲（威灵仙，Clematischi，；e。；sts（）sbeck）被广泛应用于治疗关节炎、关节痛、头痛及炎症等疾病．Clemochinenoside－A（玉）是从该植物根中分离得到的非常少见的大环内酯糖吉化合物［’j，为进一步研究其特殊结构和药理活性，我们对1进行了全合成．本文报道呈的前体化合物10的立体选择性合成．其关键步骤是6的立体选择性青化和9的位置选择性甲磷酸化反应．互结果与讨论…     

细胞粘附位点RGD前体二肽的化学合成与酯化

摘要利用一种新颖的化学法合成了细胞粘附位点RGD前体二肽GD(Gly-Asp). 并利用ROH-HCl法进一步完成了GD二肽乙酯化和甲酯化. 考察了GD二肽对乙醇/甲醇的摩尔比,  反应温度和反应时间对酯化收率的影响, 使GD二肽酯化的条件得到了优化, GD二肽对乙醇/甲醇的摩尔比为1∶40,  反应温度30℃,  反应时间1~2.5 h,   最大收率为80%~85%. 利用质谱分析法确证了两种GD二肽酯为Gly-Asp-(OEt)2 和Gly-Asp-(OMe)2.     

5-氟尿嘧啶-β-环糊精前药的合成

为达到5-氟尿嘧啶结肠靶向释药的目的,合成了不同取代度的5-氟尿嘧啶-β-环糊精前药,其结构经UV-vis,1H NMR,13CNMR,IR,ESI-MS和元素分析表征.     

Litsenolide C2前体化合物的立体专一性合成

ＬｉｔｓｅｎｏｌｉｄｅＣ２前体化合物的立体专一性合成陈祖兴黄精美（湖北大学化学系武汉４３００６２）ＬｉｔｓｅｎｏｌｉｄｅＣ２（１）是从樟科植物中分离得到的一种具有抗肿瘤活性的化合物［１］，其高度的细胞毒性和独特的结构引起了人们广泛的关注。在已报道的合...     

聚（2,5—二甲氧基对苯乙炔）的可溶性前聚物合成及表征

研究了合成聚（２，４－二甲氧基对苯乙炔）的有机可溶性前聚物的反应条件与单体转化率和前聚物产率的关系。实验结果表明：ＮａＯＨ是聚合反应的有效引发剂，适宜的反应条件为：单体与ＮａＯＨ摩尔比为１：１，单体浓度０．０５－０．２ｍｏｌ／Ｌ，聚合时间２ｈ，温度低５℃，正己烷、石油醚作为有机提取剂可有效提高前聚物产率。用ＩＲ、ＵＶ－Ｖｉｓ＇＾ＨＮＭＲ，ＴＧＡ和 ＤＳＣ对前聚物进行了表征。     

多相酶膜反应器合成生物活性二肽

生物活性肽;多相酶膜反应器合成生物活性二肽     

解热镇痛药——双膦酸酯化合物的合成

利用具有趋骨性和抗炎镇痛活性的双膦酸化合物与治疗风湿性关节炎的解热镇痛药的加和作用，设计并合成了５个解热镇痛药－－双膦酸酯偶联物，希望得到骨靶向性的治疗骨关节炎的先导物。     

扩环氮杂环卡宾前体鎓盐的合成进展

氮杂环卡宾(N-heterocyclic carbenes,NHCs)作为一种新兴配体,在现代有机化学中有非常重要的应用.有关NHCs的初期研究较多集中在易于合成、性质稳定的咪唑衍生五元-NHCs及其金属化合物,近年研究发现的六元、七元等扩环-NHCs,由于其独特的立体和化学特性而成为现代有机化学的又一研究热点.氮杂环鎓盐去质子化是获得NHCs的常用方法,因而扩环-NHCs前体鎓盐的合成是影响扩环-NHCs研究进展的一个重要因素,就近年来扩环-NHCs前体鎓盐的合成进展作一综述.     

Optimised synthesis of a nitroCBI hypoxia-activated prodrug with substantial anticancer activity

An optimised synthesis of a hypoxia-activated anticancer prodrug related to the duocarmycin family of natural products is described. The improved 10-step synthesis increases the overall yield from 4.4% to over 40% while requiring just 2 chromatography-based purifications. The most significant improvements optimise the isomer distribution in a key chlorosulfonylation reaction, and facilitate the removal of tin residues from a tributyltin hydride-mediated radical reaction. Improved preparations of two side chains are also reported. The new method provides practical access to sufficient material to support advanced efficacy and toxicology assessments.     

Synthesis and thermal study of the prodrug of oxamniquine

Oxamniquine polymeric prodrug with potential antischistosomal activity was prepared using dextran T-70 as a carrier, which was analysed by ¹HNMR, ¹³C NMR and IR spectroscopy. The formation of the oxamniquine salt was confirmed by thermogravimetric analysis (TG) and differential scanning calorimetry (DSC) which showed a different thermal behaviour when compared to the physical mixture.     

Calorimetric investigation of the interaction between a macromolecular prodrug of diflunisal and human platelets

The thermal effect due to the interaction between human platelets and α,β poly(N-hydroxy-ethyl)-DL-aspartamide (PHEA) or the PHEA-Diflunisal conjugate was measured by the calorimetric technique at 25°C. The experimental data confirm that PHEA is a biocompatible macromolecule and that its conjugate influences the physiological activity of human platelets.     

A novel hydroxy-bisphosphonic acid prodrug as a candidate for the delivery of ibuprofen to bone

Abstract

Active targeting with controlled delivery of anti-inflammatory drugs to the bone is not sufficiently explored. In this study, concise and novel synthesis of a hydroxy-bisphosphonic acid (HBPA) prodrug containing ibuprofen is described. The key step consisted of preparing the HBPA function from a carboxylic acid precursor, in mild conditions and using appropriate Arbuzov reactions with tris(trimethylsilyl)phosphite. This prodrug would be an excellent candidate for the treatment of bone inflammation diseases such as rheumatoid arthritis.     

地塞米松衍生物的合成及其抗肿瘤活性研究

地塞米松(dexamethasone)为人工合成的肾上皮质激素类药物,具有抗炎、应激保护[1],增强化疗药物诱导肿瘤细胞凋亡[2],促进细胞分化[3]等药理作用.     

抗肿瘤新药磷酸氟达拉宾的合成

磷酸氟达拉宾（7,fludarabine phosphate）由德国Bedex Labs开发,1991年首先在美国上市,用于治疗其它疗法无效的慢性淋巴细胞性白血病。本品摄入后经去磷酸作用生成代谢物9-β-氟阿糖腺苷（F-Ara-A）,后者在细胞内经磷酸化变成具抗肿瘤活性的F-Ara-ATP。本品的抗肿瘤机制涉及参入肿瘤细胞DNA或RNA链,使链停止延伸,以达到抑制DNA或RNA合成的目的。     

Synthesis and comparison of physicochemical, transport, and antithrombic properties of a cyclic prodrug and the parent RGD peptidomimetic

Cyclic prodrug 1 was derived from RGD peptidomimetic 2 by linking the amino and carboxylic acid groups via an (acyloxy)alkoxy linker. The formation of a cyclic prodrug can transiently alter the physicochemical properties of the RGD peptidomimetic. Cyclic prodrug 1 was synthesized via the key intermediate 8, and the synthesis of this key intermediate was accomplished using two different routes. Cyclic prodrug 1 has a smaller hydrodynamic radius and higher membrane interaction potential than those of the parent RGD peptidomimetic 2. The cell membrane permeation of cyclic prodrug 1 is twice that of the parent peptidomimetic 2. The prodrug-to-drug conversion can be carried out in isolated porcine esterase as well as human plasma. The cyclic prodrug is more stable at pH 4 than pH 7, and is very unstable at pH 10. The cyclic prodrug has antithrombic activity, suggesting that it can be converted to the RGD peptidomimetic in platelet-rich plasma (PRP).     

Synthesis and anti-tumor activities of novel oxazinyl isoflavonoids

The design, synthesis and biological evaluation of a novel series of oxazinyl isoflavonoids is described. Several analogs were shown to exhibit growth inhibitory effects against SKOV-3, DU-145 and HL-60 human colon cancer cell lines with IC(50) values in the micromolar range. The cellular potency of compounds 7e and 12h were found to have greater in vitro inhibitory activities than phenoxodiol, the parental compound currently in late-stage clinical trials for the treatment of cancer. The results shown are suitable for further lead optimization.     

小肽的合成及其作为双功能螯合剂在诊断用放射性药物中的应用

采用液相合成方法,以很高的纯度和较高的收率合成了3个新的4肽化合物MAG3-Phe-OH,MAG3-Leu-OH和MAG3-Tyr-OH。它们在温和的条件下很容易用99mTc进行标记,并在体内外显示了很高的稳定性。标记物的兔子显象显示新的标记物与99mTc MAG3有不同的代谢途径,有可能对癌细胞有较好的亲合作用而用于肿瘤显像。     

拉帕替尼新中间体的合成

通过使用市售的5-溴糠醛与2-甲磺酰基乙胺进行亲和加成得到席夫碱,该席夫碱通过还原氢化、氨基保护和与硼酸酯反应,得到一种拉帕替尼的新中间体5-((苄基(2-(甲基磺酰基)乙基)氨基)甲基)呋喃-2-基硼酸,四步反应总收率为66.32%。